Trial intelligence / Profile preview

Imiquimod 5% versus placebo for high-grade vulvar intraepithelial neoplasia

NL-OMON20043Active, not recruiting

Sponsor
University and governmental budget (90%), and a small unrestricted research grand from 3M Nederland (10%) and studymedication with randomizationcode.
Start
Apr 2001
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in vulvar intraepithelial neoplasia (VIN) comparing Imiquimod 5% cream with Placebo cream (2 arms). Primary endpoint: Reduction in lesion size. Started Apr 2001; status: active, not recruiting.

02

Drugs

imiquimod
03

Conditions

vulvar intraepithelial neoplasia (VIN)

Beyond the preview

Go deeper on NL-OMON20043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call